Skip to main content
Journal of Pharmacy & Bioallied Sciences logoLink to Journal of Pharmacy & Bioallied Sciences
. 2025 Jan 30;16(Suppl 5):S4245–S4247. doi: 10.4103/jpbs.jpbs_1306_24

The Crucial Role of Smoking Cessation in Preventing Oral Cancer

Prabhu Manickam Natarajan 1, Bhuminathan Swamikannu 2,, Rajan Rahe 3, Bindu Kamaraj 4, Loganathan Kamaraj 5, Veerakumar Ramachandran 6
PMCID: PMC11888749  PMID: 40061748

ABSTRACT

Oral cancer remains a significant public health concern globally, with smoking being a primary risk factor. Smoking cessation has been identified as a crucial intervention in reducing the incidence of oral cancer. This abstract reviews the impact of smoking cessation on oral cancer prevention, emphasizing the benefits of quitting smoking in decreasing the risk of developing oral malignancies. Evidence suggests that smoking cessation not only reduces the immediate risk of oral cancer but also contributes to long-term health improvements. The mechanisms through which smoking cessation exerts its protective effects, including the reduction of carcinogenic exposure and enhancement of oral mucosal health, are discussed. Public health strategies and interventions aimed at promoting smoking cessation are also highlighted as essential components in oral cancer prevention efforts.

KEYWORDS: Carcinogenic exposure, oral cancer, oral mucosal health, public health, risk reduction, smoking cessation

INTRODUCTION

Smoking is a well-known health hazard linked to a myriad of serious illnesses, including lung disease, heart disease, and various cancers. Among these, oral cancer is a particularly devastating consequence of tobacco use, affecting the lips, tongue, cheeks, gums, floor of the mouth, and throat. The connection between smoking and oral cancer is well-established, with tobacco use being the leading cause of this deadly disease. However, the good news is that smoking cessation can dramatically reduce the risk of developing oral cancer, underscoring the vital importance of quitting tobacco for both individuals and public health.[1]

Oral cancer is a type of head and neck cancer that develops in the tissues of the mouth or throat. Tobacco smoke contains over 7,000 chemicals, hundreds of which are toxic, and at least 70 are known carcinogens, meaning they can cause cancer. These carcinogens, such as formaldehyde, benzene, and nitrosamines, damage the DNA in cells lining the mouth and throat, leading to mutations that can result in cancer.[2]

Smokers are six times more likely to develop oral cancer than non-smokers. The risk is dose-dependent, meaning the more you smoke, the greater your risk. Moreover, the combined use of tobacco and alcohol significantly increases the risk, as alcohol can act as a solvent, enhancing the absorption of tobacco carcinogens in the mouth’s tissues.

Smoking cessation plays a crucial role in preventing oral cancer, a serious and potentially life-threatening condition. Oral cancer encompasses cancers of the lips, tongue, cheeks, gums, and the roof or floor of the mouth. Smoking is a major risk factor for oral cancer due to the carcinogenic substances found in tobacco, which can cause genetic mutations and damage to the cells in the oral cavity.[3]

Quitting smoking significantly reduces the risk of developing oral cancer, as the harmful chemicals that contribute to cancer development are no longer introduced into the body. The benefits of cessation extend beyond reducing cancer risk; they also improve overall oral health, enhance healing after dental procedures, and lead to a better quality of life. By addressing smoking habits and encouraging cessation, we can make significant strides in reducing the incidence of oral cancer and promoting healthier communities.[4]

The impact of smoking cessation on oral cancer risk

The decision to quit smoking is one of the most effective ways to reduce the risk of developing oral cancer. Studies have shown that smoking cessation can lead to a significant decrease in oral cancer risk, even for long-term smokers. Within five years of quitting, the risk of developing oral cancer is cut in half compared to those who continue to smoke. After 10 years, the risk approaches that of someone who has never smoked, highlighting the body’s remarkable ability to heal from the damage caused by tobacco.[5,6]

Quitting smoking also improves the outcomes for individuals who have already been diagnosed with oral cancer. Smoking cessation during treatment can enhance the effectiveness of therapies such as surgery, radiation, and chemotherapy, and it reduces the likelihood of cancer recurrence or the development of secondary cancers. Moreover, patients who quit smoking experience fewer complications during recovery and have a better overall prognosis.[7]

Challenges in smoking cessation and the role of healthcare providers

Despite the clear benefits, quitting smoking is notoriously difficult due to the addictive nature of nicotine, a substance found in tobacco. Many smokers make multiple attempts to quit before achieving long-term success. This is where healthcare providers play a crucial role. By offering evidence-based interventions, such as counseling, nicotine replacement therapy, and prescription medications, healthcare professionals can significantly improve the chances of successful smoking cessation.[8]

Dentists and dental hygienists, in particular, are in a unique position to help patients quit smoking. Regular dental visits and evaluation of saliva provide an opportunity to screen for early signs of oral cancer and to discuss the risks associated with tobacco use.[9] Dental professionals can also offer personalized cessation support, monitor progress, and provide encouragement, making them key allies in the fight against oral cancer.

Public health implications

At the public health level, smoking cessation programs are essential for reducing the incidence of oral cancer. Campaigns that raise awareness about the dangers of tobacco use and provide resources for quitting can have a profound impact. For example, graphic warning labels on cigarette packs, anti-smoking advertisements, and increased taxes on tobacco products have all been shown to decrease smoking rates.

Additionally, public health initiatives that target young people are critical, as most smokers begin using tobacco in their teens or early adulthood. Preventing tobacco use in this population can avert a significant number of future oral cancer cases.[10]

CONCLUSION

Smoking is the leading cause of oral cancer, but the decision to quit can drastically reduce the risk. Smoking cessation not only lowers the likelihood of developing oral cancer but also improves outcomes for those already affected by the disease. Operational guidelines for establishing smoking cessation centres in medical institutions are available for helping those interested in smoking cessation. Despite the challenges associated with quitting, support from healthcare providers and public health initiatives can make a significant difference. By prioritizing smoking cessation, we can take a major step toward preventing oral cancer and improving overall public health.

Conflicts of interest

There are no conflicts of interest.

Funding Statement

Nil.

REFERENCES

  • 1.Marron M, Boffetta P, Zhang Z, Zaridze D, Wunsch-Filho V, Winn DM, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol. 2010;39:182–96. doi: 10.1093/ije/dyp291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Umapathy VR, Natarajan PM, Swamikannu B. Molecular and therapeutic roles of non-coding RNAs in oral cancer—A review. Molecules. 2024;29:2402. doi: 10.3390/molecules29102402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–94. [PMC free article] [PubMed] [Google Scholar]
  • 4.Poirier AE, Ruan Y, Volesky KD, King WD, O’Sullivan DE, Gogna P, et al. The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results. Prev Med. 2019;122:140–7. doi: 10.1016/j.ypmed.2019.04.007. [DOI] [PubMed] [Google Scholar]
  • 5.Umapathy VR, Prabhu MN, Bhuminathan S, Jaber AA. Therapeutic application of lycopene in preventing oral diseases-A review. Res J Pharm Technol. 2024;17:1393–7. [Google Scholar]
  • 6.Foy J-P, Bertolus C, Saintigny P. Oral cancer prevention worldwide: Challenges and perspectives. Oral Oncol. 2019;88:91–4. doi: 10.1016/j.oraloncology.2018.11.008. [DOI] [PubMed] [Google Scholar]
  • 7.Lippman SM, Sudbø J, Hong WK. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005;23:346–56. doi: 10.1200/JCO.2005.09.128. [DOI] [PubMed] [Google Scholar]
  • 8.Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;7:CD001829. doi: 10.1002/14651858.CD001829.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Umapathy VR, Natarajan PM, Swamikannu B. Review insights on salivary proteomics biomarkers in oral cancer detection and diagnosis. Molecules. 2023;28:5283. doi: 10.3390/molecules28135283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EEW, Lin HY, et al. Erlotinib and the risk of oral cancer: The erlotinib prevention of oral cancer (EPOC) randomized clinical trial. JAMA Oncol. 2016;2:209–16. doi: 10.1001/jamaoncol.2015.4364. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Pharmacy & Bioallied Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES